Celldex Therapeutics, Inc.
NASDAQ:CLDX · NASDAQ Capital Market
+$0.16 today
Vol 1.83M · Avg 0.94M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+59.05%
Period High
$34.55
Period Low
$20.01
Latest
$32.43
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$5.33B
uniQure N.V.
NASDAQ:QURE
$2.99B
Vera Therapeutics, Inc.
NASDAQ:VERA
$2.52B
Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
$1.92B
Nuvation Bio Inc.
NYSE:NUVB
$1.88B
Immunome, Inc.
NASDAQ:IMNM
$1.74B
Sionna Therapeutics, Inc.
NASDAQ:SION
$1.69B
AbCellera Biologics Inc.
NASDAQ:ABCL
$1.67B
Biohaven Ltd.
NYSE:BHVN
$1.42B
Janux Therapeutics, Inc.
NASDAQ:JANX
$852.94M
What is the latest CLDX filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does CLDX have?
Intrinsic Alpha currently shows 20 recent filings for CLDX.
Explore More
Continue the stock analysis
Jump to another research area for this company.